Adma Biologics Stock Analysis

ADMA Stock Analysis Notes

About 91.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Adma Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 527 people. For more info on ADMA Biologics please contact Adam Grossman at 201 478 5552 or go to https://www.admabiologics.com.

ADMA Biologics Investment Alerts

ADMA Biologics Upcoming and Recent Events

ADMA Largest EPS Surprises

View All Earnings Estimates

ADMA Biologics Environmental, Social, and Governance (ESG) Scores

ADMA Stock Institutional Investors

Note, although ADMA Biologics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ADMA Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.01 B.

ADMA Profitablity

The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33.

Management Efficiency

ADMA Biologics has return on total asset (ROA) of 0.1989 % which means that it generated a profit of $0.1989 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3555 %, meaning that it created $0.3555 on every $100 dollars invested by stockholders. ADMA Biologics' management efficiency ratios could be used to measure how well ADMA Biologics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to -0.09. In addition to that, Return On Capital Employed is expected to decline to 0.07. At present, ADMA Biologics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 269.9 M, whereas Other Assets are forecasted to decline to 0.95.

Technical Drivers

As of the 25th of November, ADMA Biologics shows the Risk Adjusted Performance of 0.0729, mean deviation of 2.97, and Semi Deviation of 3.62. ADMA Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

ADMA Biologics Price Movement Analysis

ADMA Biologics Insider Trading Activities

ADMA Biologics Outstanding Bonds

ADMA Biologics Predictive Daily Indicators

ADMA Biologics Corporate Filings

ADMA Biologics Forecast Models

ADMA Biologics' time-series forecasting models are one of many ADMA Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ADMA Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ADMA Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ADMA shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ADMA Biologics. By using and applying ADMA Stock analysis, traders can create a robust methodology for identifying ADMA entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ADMA analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ADMA analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ADMA Biologics stock analysis indicators help investors evaluate how ADMA Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ADMA Biologics shares will generate the highest return on investment. By understating and applying ADMA Biologics stock analysis, traders can identify ADMA Biologics position entry and exit signals to maximize returns.

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.